Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.04B | 1.14B | 1.56B | 1.66B | 1.05B |
Gross Profit | 243.30M | 238.30M | 269.40M | 292.50M | 178.30M |
EBITDA | 65.00M | 44.50M | 23.70M | 51.10M | 26.90M |
Net Income | 24.70M | -2.60M | -30.40M | 17.70M | 1.70M |
Balance Sheet | |||||
Total Assets | 441.80M | 460.30M | 549.20M | 615.70M | 449.00M |
Cash, Cash Equivalents and Short-Term Investments | 40.10M | 19.10M | 19.50M | 67.10M | 6.90M |
Total Debt | 70.90M | 95.30M | 153.60M | 95.30M | 106.00M |
Total Liabilities | 304.00M | 354.60M | 476.80M | 519.30M | 369.30M |
Stockholders Equity | 137.80M | 105.70M | 73.40M | 97.70M | 80.70M |
Cash Flow | |||||
Free Cash Flow | 53.30M | 22.30M | -62.00M | 105.50M | 6.10M |
Operating Cash Flow | 61.60M | 24.40M | -52.40M | 114.60M | 14.10M |
Investing Cash Flow | -7.60M | 7.70M | -9.60M | -9.10M | -7.90M |
Financing Cash Flow | -33.00M | -32.30M | 14.40M | -45.30M | -28.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | £1.23B | 11.30 | 5.01% | ― | -10.46% | 396.13% | |
64 Neutral | £689.62M | ― | 890.75% | 0.48% | 5.32% | -152.26% | |
63 Neutral | £529.67M | 50.87 | 6.87% | ― | -0.39% | 2.68% | |
62 Neutral | $16.51B | 10.46 | -8.28% | 3.32% | 1.44% | -22.58% | |
55 Neutral | £468.89M | ― | -27.20% | ― | -14.37% | -28.78% | |
51 Neutral | £383.10M | ― | -62.59% | ― | -15.86% | -18.46% | |
48 Neutral | £232.75M | ― | -96.36% | ― | -16.32% | -202.39% |